⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 31, 2024PhytomedicineOpen Access

QingChang-XiaoPi decoction ameliorates intestinal inflammation of ulcerative colitis by regulating the pathogenicity of Th17 cells

Rui Jia Huan Zheng Siya Li Weihuan Chen Yuanming Yang Haomeng Wu Haiming Chen Shumin Qin Shaogang Huang

View Full Paper

Ask AI

Bookmark

Share

Abstract

QingChang-XiaoPi Decoction (QCXPY), a Chinese herbal prescription, has been employed in the treatment of ulcerative colitis (UC) in China. However, its molecular mechanism of action in UC remains unclear.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jia et al. (2024) studied this question.

synapsesocial.com/papers/68e67624b6db643587600674 https://doi.org/10.1016/j.phymed.2024.155779

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Changdiqing decoction (CDQD) ameliorates colitis via suppressing inflammatory macrophage activation and modulating gut microbiotaOriginal Research · 2025 · 12 citations
2Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK–ATF4–CHOP pathway of ER stress and the NF-κB signalling pathway2024 · 7 citations
3Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice2024 · 4 citations
4Xuanbi Yuyang Decoction Ameliorates DSS-Induced Colitis by Inhibiting Pyroptosis via Blocking of IL-17 Pathway Activation2024 · 5 citations
5Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis2024 · 3 citations